4//SEC Filing
Fiore Maximillian D 4
Accession 0001235802-11-000119
CIK 0001114200other
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 12:14 PM ET
Size
19.0 KB
Accession
0001235802-11-000119
Insider Transaction Report
Form 4
Fiore Maximillian D
Sr. VP and Chief Tech. Officer
Transactions
- Disposition to Issuer
Common Stock
2011-06-17−2,727→ 5,176 total - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−56,875→ 73,125 totalExercise: $15.09Exp: 2016-08-02→ Common Stock (56,875 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−73,125→ 0 totalExercise: $15.09Exp: 2016-08-02→ Common Stock (73,125 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−23,970→ 0 totalExercise: $18.46Exp: 2017-02-11→ Common Stock (23,970 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−34,210→ 0 totalExercise: $20.05Exp: 2018-02-10→ Common Stock (34,210 underlying) - Disposition to Issuer
Stock Option (right to buy)
2011-06-17−7,990→ 23,970 totalExercise: $18.46Exp: 2017-02-11→ Common Stock (7,990 underlying) - Disposition to Issuer
Common Stock
2011-06-17−5,176→ 0 total
Footnotes (7)
- [F1]Pursuant to the merger of a wholly-owned subsidiary of Endo Pharmaceutials Holdings Inc. ("Endo") with and into American Medical Systems Holdings, Inc. (the "Merger"), such shares were disposed of in exchange for $81,810 in cash.
- [F2]These restricted shares were assumed by Endo in the Merger in exchange for 3,910 restricted shares of Endo common stock, having a market value of $38.32 per share on the effective date of the Merger. The vesting terms of the new Endo restricted stock grants will remain the same as the vesting terms of the old grants.
- [F3]This option, vested with respect to 25% of the shares on June 30, 2010 and with respect to the remaining shares, quarterly over the next three years, was canceled, with respect to 56,875 shares, in the Merger in exchange for a cash payment of $848,006.25 representing the difference between the exercise price of the option and the $30.00 per share price.
- [F4]This option, which vested with respect to 25% of the shares on June 30, 2010 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 55,245 shares of Endo common stock with an exercise price of $19.98 per share.
- [F5]This option, which vested with respect to 25% of the shares on March 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was canceled, with respect to 7,990 shares, in the Merger in exchange for a cash payment of $92,204.60 representing the difference between the exercise price of the option and the $30.00 per share price.
- [F6]This option, which vested with respect to 25% of the shares on March 31, 2011 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 18,109 shares of Endo common stock with an exercise price of $24.44 per share.
- [F7]This option, which vested with respect to 25% of the shares on March 31, 2012 and with respect to the remaining shares, quarterly over the next three years, was assumed by Endo in the Merger and replaced with an option to purchase 25,845 shares of Endo common stock with an exercise price of $26.54 per share.
Documents
Issuer
AMERICAN MEDICAL SYSTEMS HOLDINGS INC
CIK 0001114200
Entity typeother
Related Parties
1- filerCIK 0001469575
Filing Metadata
- Form type
- 4
- Filed
- Jun 20, 8:00 PM ET
- Accepted
- Jun 21, 12:14 PM ET
- Size
- 19.0 KB